Nuvilex, Inc. Announces Completion Of Acquisition Of Pancreatic Cancer Treatment Technology
Links shared publicly online about this topic.
- 262total visits
Nuvilex, Inc. Announces Completion Of Acquisition Of Pancreatic Cancer Treatment Technology
Nuvilex, Inc. (OTCQB: NVLX) announces it has completed the acquisition of pancreatic cancer treatment technology from a world leader in living-cell encapsulation technology. The technolog
View full resource at medicalnewstoday.com
Tags: Pancreatic Disease, Cancer, Pancreatic Cancer
Most Recently Shared on May 27, 2011 at 4:06 pm By:
Nuvilex, Inc. Announces Completion Of Acquisition Of Pancreatic Cancer Treatment Technology http://mnt.to/3Wt5 #pancreaticcancer
Also Shared By:
Nuvilex, Inc. Announces Favorable Phase II Clinical Trial Results For Pancreatic Cancer
medicalnewstoday.com — “Nuvilex, Inc. (PINK SHEETS: NVLX) announces the favorable results of a completed Phase II clinical trial carried out in Europe against pancreatic cancer. The treatment technology used in this tria” View full resource at medicalnewstoday.com
Most Recently Shared on June 2, 2011 at 12:07 pm By:
MNT Pancreatic Can Health News
Nuvilex, Inc. Announces Favorable Phase II Clinical Trial Results For Pancreatic Cancer http://mnt.to/3WGt #pancreaticcancer
Advertisement
MNT Cancer News
@mnt_cancer
Nuvilex, Inc. Announces Favorable Phase II Clinical Trial Results For Pancreatic Cancer http://mnt.to/3WGt #cancer
1 year ago...